SCHEDULES TO THE CONSOLIDATED 5 FINANCIAL STATEMENTS I I (thousands of dollars) SUB-SCHEDULE 2B - EXECUTIVE SALARIES AND BENEFITS FOR THE YEAR ENDED MARCH 31, 2013 2013 Pay-at-Risk Other Non- For the Current Fiscal Year Base Salary Component Other Cash Cash Benefits Benefits Subtotal Severance Total Board Direct Reports Dr. Chris Eagle -- President and Chief Executive Officer 580 108 41 65 794 - 794 Ronda White -- Chief Audit Executive 206 29 - 41 276 - 2?6 Noela lnions -- Ethics and Compliance Officer 225 -- 60 285 - 235 Patti Grier -- Chief of Staff and Corporate Secretary 192 29 33 254 - 254 CEO Direct Reports Chris lvlazurkewich -- Executive VP and Chief Operating Officer 468 93 22 64 647 - 547 Duncan Campbell -- Executive VP and Chief Financial Officer - - - - - -- -- Allaudin Merali -- Executive VP and Chief Financial Officer 98 - 10 9 115 115 Deborah Rhodes -- Acting Chief Financial Officer 245 34 2 33 319 - 319 Dr. David Megran -- Executive VP and Chief Medical Officer, Clinical Operations 435 93 48 176 305 -- 805 Dr. Vema Yiu Executive VP and Chief Medical Officer, Quaiity and Medical Affairs 318 52 38 22 425 - 426 Bill Trafford -- Executive vP and Chief Development Officer 339 55 22 so 472 - 472 Stephen Gould -- Executive VP, People and Partners 411 B9 32 68 580 -- 530 or. Todd -- Senior VP, Research 229 35 9 24 297 - 297 Barbara Pitts -- Senior VP. Priorities and Performance 156 23 - 35 214 - 214 Deb Gordon -- Senior VP, Health Professions Strategy and Practice and Chief Nursing and Health Professions Officer 83 12 - 15 110 - 110 Total Executive 4,031 637 220 706 5,594 5.594 IEITUUV BLOB -- ZLOZ